Atopic Dermatitis Upcoming Therapies

View All

atopic-dermatitis-treatment-pipeline
Atopic Dermatitis Treatment: Rich Portfolio of Therapeutic Options Shaping the Future

Atopic dermatitis is common worldwide, and people of all ages, from newborns to adults 65 and older, live with this condition. The World Health Organization (WHO) Global Burden of Diseases initiative estimates more than 230 million people globally have atopic dermatitis and that skin diseases are the fourth leading...

Find More

Atopic dermatitis market
Atopic dermatitis market and a Dupilumab dominance

Dupilumab, a monoclonal antibody, is administered in the form of injection for the treatment of Atopic dermatitis (Eczema) in adults and children of age 12 and old. The injection works by hampering the substance in the body, which produces allergic reactions. Dupilumab is a receptor-antagonist and binds to the alph...

Find More